Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects

• Status: Completed
• Trial end date: 2013-01-01

Summary

The purpose of this study is to:

1. Compare the pharmacokinetics profiles of pregabalin sustained release tablet (300mg) to immediate release capsule(150mg * 2).

2. Evaluate the effectiveness of food to pharmacokinetics profile of Pregabalin sustained release tablet.

• Phase: Phase 1

Details

• Lead Sponsor: IlDong Pharmaceutical Co Ltd
• Treatments: Pregabalin